Autori: Kim Sung Bae
| Naslov | Phase III of oral paclitaxel (DHP107) vs intravenous paclitaxel in HER2-negative recurrent or metastatic breast cancer (mBC): Primary analysis of a multinational optimal trial (NCT03315364). (Meeting Abstract) |
| Autori | Kim Sung Bae ... Kostic Sanja V ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2025), vol. 43 br. 16_SUPPL, Suppl. 16_SUPPL, str. 1007-1007 |
| Projekat | DAEWHA PHARM. CO., LTD. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
